FDA DrugClass IINotable
FDA Recall: NAPROXEN ORAL SUSPENSION, USP, 125 mg/5mL, Rx only, 16fl oz (473 mL) bottles, Distributed by: Acella
Description
Chemical contamination; presence of lead and lithium above specification
Hazard
Chemical contamination; presence of lead and lithium above specification
Remedy
6,336 bottles
Related Recalls
2026-05-13 · FDA_DRUG
FDA Recall: BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Steri
CareFusion 213, LLC
2026-05-13 · FDA_DRUG
FDA Recall: BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Steri
CareFusion 213, LLC
2026-05-13 · FDA_DRUG
FDA Recall: TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dos
Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles
2026-05-13 · FDA_DRUG
FDA Recall: DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperiton
Fresenius Medical Care Holdings, Inc.